Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:48 AM
Ignite Modification Date:
2025-12-25 @ 4:48 AM
NCT ID:
NCT05088018
Eligibility Criteria:
Inclusion Criteria:
* Veteran status
* MOS Sleep Problems Index II \> 30
* California resident
* Participants must own their own smartphone device to use for the study. Devices must meet the following criteria:
* Participants must be comfortable reading study instructions in English and communicating with study team in English
* Be willing to commit to study dosing, completing evaluation instruments, and following study protocol activities.
* If female and of childbearing potential, agree to use an effective form of birth control during study participation.
Exclusion Criteria:
* If using sleep medications, medication and dosage have not been changed in the past month and will remain unchanged for the duration of the study
* If using other psychotropic medications, medication and dosage have not been changed in the past 2 months, and will remain unchanged for the duration of the study
* Prior observation that the prospective participant has stopped breathing or observed choking/gasping during their sleep
* Previous diagnosis of sleep apnea (participant reported) without use of a CPAP (or similar PAP device) for at least the prior 4 weeks
* Currently in a Cognitive Behavioral Therapy for Insomnia (CBTI) program
* Women who are currently pregnant, trying to become pregnant, or breastfeeding
* Currently using CBG on a regular basis
* Participant has already participated in this study
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
21 Years
Study:
NCT05088018
Study Brief:
Protocol Section:
NCT05088018